XML 43 R33.htm IDEA: XBRL DOCUMENT v3.3.1.900
Revenue Recognition (Details Textual) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Revenue Recognition [Line Items]        
Revenue, Net, Total $ 448,000 $ 7,000 $ 914,000 $ 13,000
License and Maintenance Revenue     21,000 $ 43,000
KOREA, REPUBLIC OF | Korean Pharmaceutical Company [Member]        
Revenue Recognition [Line Items]        
Deferred Revenue 500,000   $ 500,000  
Deferred Revenue Recognition Period     10 years 10 years
CANADA | Canadian Based Supplier [Member]        
Revenue Recognition [Line Items]        
Deferred Revenue $ 250,000   $ 250,000  
Deferred Revenue Recognition Period     7 years 7 years